Loading…
BALAXI PHARMACEUTICALS (BALAXI)₹22.66+1.43%Pharmaceuticals
BALAXI PHARMACEUTICALS is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 55.3 against a peer median of 20.2, and ROCE of 3.0% against a peer median of 11.1%, and latest-quarter sales growth of 14.1% against a peer median of 25.3%. By market cap it is #8 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Par Drugs and Chemicals | 139 | 9.6 | 17.0 | 12.4 | 0.00 | 0.0 | 104 | 13 | 20.2 | 41.6 | vs BALAXI |
| Speciality Medicines | 136 | 10.4 | 25.0 | 25.5 | 0.09 | 0.0 | 75 | 13 | 45.2 | 166.1 | vs BALAXI |
| Parnax Lab | 134 | 15.0 | 14.0 | 14.4 | 0.87 | 0.0 | 249 | 12 | 6.4 | −86.6 | vs BALAXI |
| Bal Pharma | 132 | 18.6 | 10.0 | 7.9 | 1.96 | 1.4 | 313 | 6 | 34.5 | 460.0 | vs BALAXI |
| Lactose (India) | 132 | 21.9 | 11.1 | 9.8 | 0.96 | 0.0 | 163 | 6 | 64.9 | 190.8 | vs BALAXI |
| Krebs Biochemicals and Industries | 129 | — | −15.0 | — | — | 0.0 | 24 | −17 | 27.4 | — | vs BALAXI |
| Asston Pharmaceuticals | 129 | 33.3 | 16.8 | 15.5 | 0.13 | 0.0 | 25 | 4 | 10.8 | −75.8 | vs BALAXI |
| BALAXI PHARMACEUTICALS | 125 | 55.3 | 3.0 | 0.6 | 0.23 | 0.0 | 270 | 1 | 14.1 | 336.7 | — |
| Parnax Lab | 125 | 14.0 | 14.1 | 14.4 | 0.87 | 0.0 | 249 | 12 | 6.4 | −86.6 | vs BALAXI |
| Godavari Drugs | 122 | 24.2 | 7.0 | 6.4 | 1.00 | 0.0 | 106 | 4 | 30.1 | 45.5 | vs BALAXI |
| Alpa Laboratories | 119 | 28.6 | 9.1 | 8.3 | 0.02 | 0.0 | 106 | 15 | 25.3 | −91.6 | vs BALAXI |
| Peer median | 129 | 20.2 | 11.1 | 11.1 | 0.55 | 0.0 | 106 | 6 | 25.3 | 43.5 |
Listed companies closest to BALAXI PHARMACEUTICALS in Pharmaceuticals include Par Drugs and Chemicals, Speciality Medicines, Parnax Lab, Bal Pharma, Lactose (India), Krebs Biochemicals and Industries, Asston Pharmaceuticals, Parnax Lab.
Par Drugs and Chemicals, with a market cap of ₹139 Cr.
BALAXI PHARMACEUTICALS trades at a P/E of 55.3; the median of its peer set is 20.2. A P/E above or below the median is a description, not a judgement on value.
BALAXI PHARMACEUTICALS' return on capital employed is 3.0%, below the peer median of 11.1%.